About Dr. Sewanti Limaye
Dr. Sewanti Limaye is a distinguished medical oncologist renowned for her pioneering work in precision oncology. With over two decades of experience, Dr. Limaye has been instrumental in advancing cancer treatment protocols in India. As the Director of Medical & Precision Oncology at Sir H. N. Reliance Foundation Hospital, Dr. Sewanti Limaye established one of the country’s first precision oncology clinics led by a medical oncologist, significantly enhancing the hospital’s clinical and translational research capabilities.
Patients seeking expert care can easily schedule a Dr. Sewanti Limaye appointment to benefit from her extensive expertise in oncology. Recognised as a leading oncologist, Dr. Sewanti Limaye’s commitment to personalised cancer treatment continues to make a profound impact on patient outcomes nationwide.
- Medical Degrees: MBBS – Jawaharlal Nehru Medical College, Bhagalpur, India
- Postgraduate Education: MD in Internal Medicine – New York University School of Medicine, USA
- Fellowships & Special Training:
- Fellowship in Hematology and Medical Oncology – North Shore–Long Island Jewish Health System (Northwell Health), USA
- Advanced Training in Early Drug Development – Dana-Farber Cancer Institute / Brigham and Women’s Hospital (Harvard Medical School), Boston, USA
- Master’s Degree: MS in Patient-Oriented Research (Cancer Genomics & Biostatistics) – Columbia University Mailman School of Public Health, New York, USA.
- Certifications & Accreditations:
- Board Certified in Internal Medicine – USA
- Board Certified in Hematology – USA
- Board Certified in Medical Oncology – USA
- Breast Cancer
- Lung Cancer
- Head & Neck Cancers
- GI Cancers (colorectal, gastric, pancreatic, liver)
- GU Cancers (prostate, bladder, kidney)
- Gynecologic Cancers (ovarian, endometrial, cervical)
- Sarcomas
- Brain Tumors (with neuro-oncology teams)
- Precision Oncology – Tailored treatments via genomic profiling
- Targeted Therapy & Immunotherapy – Advanced biologics and immune treatments
- Early Phase Drug Development – Implementation of novel drug protocols
- Clinical & Translational Research – Bridging lab discoveries to clinical application
- Molecular Tumor Board Leadership
- Genomic Testing Integration
- Systemic Therapy Administration (targeted drugs, immunotherapy, chemotherapy)
- Clinical Trial Leadership – Design and execution of key oncology trials
- Director – Medical & Precision Oncology, Reliance Foundation Hospital, Mumbai
- Assistant Professor – Columbia University, USA
- Fellow – North Shore LIJ Health System, New York
- Fellow – Dana-Farber / Brigham and Women’s Hospital, Boston
- Founder, Iylon Precision Oncology
- National Chair, NCI-MATCH Trial Sub-protocol
- Global Research Collaborations – MSKCC, Dana-Farber, NCI, Columbia
- ASCO Young Investigator Award (2008)
- John Flynn & Horowitz Awards for Excellence
- Over 100 publications on genomics, profiling, and therapeutic innovations
- Actively involved in trials for Pembrolizumab, Durvalumab, Olaparib, Larotrectinib, Savolitinib, and Osimertinib
Treatment Type | Cost Range (INR) | Cost Range (USD) |
Chemotherapy (per session) | ₹4,000 – ₹150,000 | $48 – $1,796 |
Radiation Therapy (total) | ₹250,000 – ₹2,000,000 | $2,994 – $23,952 |
Immunotherapy (per session) | ₹150,000 – ₹450,000 | $1,796 – $5,389 |
“Thanks to Dr. Limaye, my aunt made a full recovery from breast cancer.”“Dr. Limaye helped us navigate my father’s prostate cancer with clarity.”“Dr. Limaye, our oncologist, guided us through a difficult time with knowledge and compassion.”